- Home
- / Yokogawa Insilico Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Yokogawa Insilico Biotechnology financials data including stock price, CreditSafe score, and balance sheet.
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|
| Cash | 381.8K | 871.4K | |
| Prepaid Expenses | 7.2K | 74.2K | 22.7K |
| Current Assets | 1.9M | 1.9M | 1.1M |
| PP&E | 12.2K | 12.7K | |
| Total Assets | 4.7M | 4.4M | 1.2M |
| Current Liabilities | 5.6M | 7.6M | 344.6K |
| Total Liabilities | 6.5M | 8.1M | 962.1K |
| Common Stock | 1.5M | 1.5M | |
| Retained Earnings | (5.3M) | (11.5M) | |
| Total Equity | (1.7M) | (3.7M) | 203.7K |
| Financial Leverage | -2.7 | -1.2 | 5.7 |